GRX
Gabelli Healthcare & WellnessRx Trust
$9.32
▲ 0.00%$9.32▲ +6.98%
over 1Y
L $8.36EODHDH $9.62
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+3.9%
1M+5.0%
3M+5.5%
YTD+0.3%
1Y+7.0%
Sell
Conviction
Horizon
Medium (3–12mo)
Mixed signals in the latest filings.
Gabelli Healthcare & WellnessRx Trust shows limited reported revenue.
Key statistics
Valuation
Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
- 8-K Other event2026-05-07
- DEF 14A Proxy statement2026-03-19
- DEF 14A Proxy statement2025-03-20
- SC 13D/A Activist / 5%+ stake change2024-08-09
- SC 13D Activist / 5%+ stake change2024-07-10
- DEF 14A Proxy statement2024-03-22
- SC 13D/A Activist / 5%+ stake change2024-03-04
- SC 13D/A Activist / 5%+ stake change2024-01-08
- DEF 14A Proxy statement2023-04-05
Recent filings
all on EDGAR ↗NPORT-PPeriod ending 2026-03-312026-06-01open ↗8-KPeriod ending 2026-05-072026-05-07open ↗DEFA14AFiling2026-03-19open ↗DEF 14APeriod ending 2026-05-112026-03-19open ↗N-CENPeriod ending 2025-12-312026-03-12open ↗N-CSRPeriod ending 2025-12-312026-03-09open ↗NPORT-PPeriod ending 2025-12-312026-03-02open ↗4Period ending 2026-01-122026-01-14open ↗4Period ending 2026-01-082026-01-12open ↗40-17GFiling2026-01-09open ↗4Period ending 2025-12-262026-01-02open ↗4Period ending 2025-12-262025-12-30open ↗
Frequently asked
- Is Gabelli Healthcare & WellnessRx Trust (GRX) a buy?
- GRX currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
Sources: SEC EDGAR (CIK 0001391437, latest NPORT-P filed 2026-06-01) · EODHD · as of 6/28/2026, 2:07:35 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.